And furthermore, while the refinement technology may be more complex than tuning Cervelos, the accounting is little complicated than counting sprockets and inner tubes. It hurts the Company's valuation for the financial reporting to be so late and (when it comes) so opaque.
"nuclear fuel is quite different than bicycles"
To be clear, I was referring to the market cap of the Company. I know of a couple of McDonalds' stores with a higher market cap the LEU's $40 million (following the recent sub-critical rally from a recent low of about $34 million).
I tried to post the bio on Mr. Miller yesterday but yahoo was apparently offended by my long C&P.
So let me just say, that he is a very experienced investor with a long history of active participation on the Boards of Directors of the companies in which he has taken a position. Centrus needs to get this guy on its board (to replace about five others on a much smaller board for this bicycle shop) with the expectation that he will be closely aligned with public shareholders' interests and that he knows how to take name and kick #$%$.
CRC recorded "$2.1 billion after-tax non-cash charges, including GAAP required adjustments for commodity prices, spin-off related items and rig terminations."
The reason that Obama (or for that matter the real commander in chief, Valerie Jarrett) won't send help to the Kurds, who desperately need it, is because he doesn't want to offend Iran by bypassing their puppets in Baghdad. The mullahs in Tehran have BHO by the nose hairs and they're not letting go.
By the way, you can look up Valerie Jarrett's place of birth should you be interested: Shiraz, Iran.
". . . where did you come across this information."
Prolly reported by Brian Williams, calling in to NBC News from his remote location . . . !
"if Rite Aid can maintain a mid-single digit comparable growth rate, and continue to improve margins, this is a stock that could easily find itself in the mid-$20s. The acquisition of EnvisionRX further supports that outlook, giving Rite Aid a better shot to make the continued improvements necessary to see a stock price in the $20s long-term."
Psst, Lewis, don't let the truth get out.
If it takes the support of enviro-whackos to get nuclear power rolling again, so be it.
"EVERYONE WHO WORKS pays in to Medicaid from every pay-check."
Huh? No more than for food stamps, or Air Force planes, or the White House gardeners.
Maybe you're thinking of Medicare.
In an article about Cameco, today's WSJ stated, ". . . today's level of 436 operable nuclear reactors world-wide should grow to 526 by 2023."
My experience was very different than yours.
As an OXY owner, I received a few shares of CRC in the spin-off. Then I bought a whole lot more in the $6+ range thinking that it would be a long-term holding.
Then I got a bad case of angina as the share price sunk to under $4. Now I'm totally out of CRC with a small realized gain.
I hope you're correct on the long-term prospects. I'd like to come back as a shareholder, but only after I have greater visibility on the long-term impact of the $6B liability on the balance sheet for the big dividend to OXY. The related question is, what will the 12/31/14 valuation write-off be.
CRC ought be be a good income annuity. We'll see.
The cynical side of me thinks that LEU's management, whoever they are this week, is all too willing to let the share price drift lower so that the strike price on yet-to-be-issued options will be as low as possible.
"Picked up another 5k."
I'm going to Las Vegas next weekend. Thinking that my chances may be "better" there.
I'm thinking that it may better to swim upstream against a casino's house odds than bet on LEU's opaque future.
Even at that discount, these bonds, maturing in 25 years, don't pay enough for the risks (including interest-rate risk). The common is riskier (in many respects) but the upside is way higher.